Anemia of prematurity
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Anemia of prematurity is a normochromic, normocytic anemia commonly seen in premature infants cared for in the neonatal intensive care unit.
Pathophysiology
The total volume of blood in premature infants is approximately 100ml/kg of body weight--approximately 5 ounces for a 1.5kg infant. Blood sampling done for laboratory testing in the first days of life can easily remove enough blood to produce anemia. As anemia develops, the amount of oxygen delivered by the hemoglobin in the blood to the body organs declines. Normally this stimulates increased production of erythropoietin (EPO), but this response is diminished in premature infants. While the reason for this decreased response is not fully understood, it is theorized that there is a genetically timed switch from hepatic production of EPO, which occurs in-utero, to renal production. Since hepatic production is stimulated by lower levels of oxygen delivery (reflecting the lower levels present in the fetus) and since the red blood cells are carrying higher amounts of oxygen after birth, the level of red blood cells itself must drop significantly before EPO production will begin in premature infants who have not yet switched from hepatic to renal EPO production. This level may be as low as a hemoglobin of 6.5g/dL, corresponding to an hematocrit of approximately 19.
Treatment
The best treatment is prevention by minimizing the amount of blood drawn from the infant. Modern technology, including non-invasive pulse-oximetry, development of laboratory equipment that can use very small blood volume samples, and in-dwelling monitors that can measure blood-gas parameters without removing any blood have helped delay or even eliminate anemia of prematurity in some infants. Recombinant EPO may be given to premature infants to stimulate red blood cell production. Premature infants are equally responsive to EPO as term infants. However, the response to EPO typically takes up to 2 weeks. To date, studies of EPO use in premature infants have had mixed results. It is likely that only a carefully selected subpopulation of infants may benefit from its use.
Outcome
Anemia of prematurity may be tolerated in the otherwise healthy premature infant without complications and will eventually spontaneously resolve when EPO production resumes. However, hemoglobin levels < 10g/dL may be associated with decreased growth, evidence of compensatory increased cardio-respiratory response (tachycardia and tachypnea), and an increase in apnea. Treatment of symptomatic anemia of prematurity is with blood transfusion.
References
Spitzer, Alan (2005). Intensive Care of the Fetus & Neonate. Elsevier, 1286. ISBN 1-56053-512-1.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
